C4 binding to artificial systems  by Reboul, Angeline et al.
Volume 133, number 1 FEBS LETTERS October 198 1 
C4 BINDING TO ARTIFICIAL SYSTEMS 
Angeline REBOUL, Marie-Bernadette VILLIERS, Nicole M. THIELENS and Maurice G. COLOMB 
Centre d’Etudes NuclPaires de Grenoble, DRF, Laboratoire de Biologic Moltculaire et Cellulaire, 85 X and 
UniversitP Scientifique et Midicale de Grenoble, ERA CNRS no. 695, Unit& INSERM no. 238, 38041 Grenoble cedex, France 
Received 22 July 1981 
1. Introduction 
Activation of complement by the classical pathway 
contributes to the non-specific defence of vertebrates 
against infection; it represents the triggering of a cas- 
cade system of proteolytic complex enzymes, Ci, the 
C3 and the C.5 convertases. The C3 convertase is a 
bimolecular complex of proteins C4b and C2ain which 
C2a contains the catalytic site able to proteolyse C3 
into two biologically active peptides C3a and C3b. C4b 
is the non-catalytic component of the C3 convertase 
[1,21. 
only a few percent of the C4b molecules have been 
shown to be hemolytically active [8]. This raises the 
problem of the reactivity of bound C4b towards C2 
and the regulatory proteins C4bp and I. 
The cleavage of C4 by Cis leads to a metastable 
activated fragment, C4b, by inducing the transient 
release of a reactive acyl group, from a thioester link- 
age in the native molecule; liberation of a free sulfhy- 
dry1 group accompanies the proteolysis of C4 into 
C4b and C4a [3,4]. Binding of C4b to acceptor sur- 
faces via the activated acyl group is the first step in 
the formation of C3 convertase. Both membranes [5] 
and Ig [6,7] can act as acceptor of C4b; the respec- 
tive participation of each is as yet not well defined. 
The efficiency of the binding mechanism is low and 
A sequential molecular analysis of the different 
steps involved in the formation of the C3 convertase 
is necessary to understand the whole sequence. We 
have studied the binding of C4b to two acceptor 
systems: Sepharose and sheep erythrocyte stroma. 
The results reported show that the binding of C4b 
to acceptors is confined only to molecules produced 
in close proximity to these acceptors. Sepharose, 
sheep erythrocyte stroma and particulate Ig act as 
acceptors taking the EACi system as a reference. 
2. Materials and methods 
All chemicals were of analytical grade. 
Human titrated plasma was obtained from the 
Centre de Transfusion Sanguine (Grenoble) and serum 
prepared as in [9]. 
Abbreviations: SDS-PAGE, sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis; STI, soybean trypsin inhibitor; 
Ig, immunoglobulins; Ag, antigen; DFP, di-isopropylphos- 
phorofluoridate; NPGB, p-nitrophenyl-p’-guanidinobenzoate; 
PBS, 10 mM phosphate buffer (pH 7.2) containing 145 mM 
NaCl; DGVB’+, 5 mM Verona1 (barbitone), 142 mM NaCl, 
2.5% glucose, 0.05%, gelatin, 0.5 mM MgCl, 0.15 mM CaCl, 
(pH 7.5); EA, erythrocytes ensitized with specific antibodies; 
EACl or EACi, EA bearing proenzymic or activated Cl ; 
ICC1 or ICCi, immune complexes bearing proenzymic or 
activated Cl 
Human complement components were purified 
as in [lo] for Cir-Cis complex, Cir, Cis and 1111 
for C4. 
Nomenclature: Components of complement follow that 
recommended by World Health Organization (1968); a bar 
indicates the activated state of a component 
SDS-PAGE of proteins was as in [9] using 5% 
(w/v) acrylamide gels. ‘2sI-Labelling of C4 and Cis- 
cleaved C4 was by the method in [ 121 or with lac- 
toperoxidase as in [ 111. “‘1 was measured with a MR 
480 Kontron counter in the various solutions or in 
1 mm gel slices after SDS-PAGE. 
Proteins were estimated according to [ 131 or from 
their Azso for purified proteins using, respectively, 
,$%a = 10, 11.5,9.5, 10.6 and 14 for C4 [3], Cir, 
C 1 s, Cir-Cis complex, and IgG [ lo]. 
Antibodies to ovalbumin were raised in rabbits 
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according to [ 141. Total immunoglobulins were puri- 
fied by Na2S04 precipitation [ 151. Specific antibodies 
were purified by immunoabsorption chromatography 
on a column of ovalbumin-Sepharose 4B. 
EACT were prepared from sheep erythrocytes (Bio- 
Merieux) sensitized with rabbit hemolysin (Behring) 
at a final dilution of 1: 1000; EA were suspended in 
human serum containing 1 mM NPGB at lo9 cells/ml 
and incubated for 30 min at 0°C to allow fixation of 
CI ; after centrifugation and washing at 4°C with 
DGVB*+ supplemented with 1.5 mM CaCl,, EAC 1 
were resuspended in this buffer at lo9 cells/ml and 
activated 45 min at 37°C to EACi. 
Proteins were coupled to Sepharose 4B as in [ 161. 
After activation of Sepharose 4B with CNBr (1 g CNBr 
for 5 ml packed Sepharose), proteins were coupled 
overnight at 4°C in 0.1 M NaHCO,, 0.1 M NaC1. The 
Cir-Cis complex was coupled in 10 mM triethanol- 
amine-HCl, 100 mM NaCl, 5 mM CaCl, (pH 8.0) and 
non-covalently bound proteins washed out by 1 M 
propionic acid containing 1 M NaCl. Sepharose was 
resuspended in twice its packed volume of buffer for 
subsequent use. 
CisDFP was obtained by blocking the active site 
of Cis by incubation for 1 h at 37°C adding 5 mM 
DFP at 0 and 30 min. Calcium-dependent binding 
of CIs to Sepharose-Cis. Sepharose-CisDFP and 
Sepharose-Cir, in 50 mM Tris-HCl, 150 mM NaCI. 
5 mM CaCl, (pH 7.4) was done by incubation for 
15 min at 4°C with Cls in equivalent amount to the 
Sepharose-bound protein. 
To prepare Sepharose-ICCi, 1 ml packed 
Sepharose-ovalbumin, corresponding to 4 mg bound 
ovalbumin, was suspended for 15 min at 4’C in 10 ml 
50 mM Tris-HCl. 1.50 mM NaCl (pH 7.4) containing 
15 mg of anti-ovalbumin Ig. The suspension was washed 
at 4°C by 30 ml 50 mM Tris-HCl, 150 mM NaCl, 
5 mM CaCl, (pH 7.4) and 20 ml of the same buffer 
containing 1 mM NPGB, then incubated for 30 min at 
4°C in 20 ml human serum containing 1 mM NPGB. 
After this incubation the Sepharose was washed at 
4°C by 20 ml 50 mM Tris-HCl. 100 mM NaCl, 50 mM 
CaCl,, 1 mM NPGB (pH 7.4) and 30 ml of the same 
buffer without NPGB. Sepharose-ICC1 was then 
resuspended in the last buffer, incubated for 30 min 
at 37”C, filtered and this step was repeated once 
leading to the activation of Sepharose-ICC 1 to 
Sepharose-ICCi. The same protocol was used to 
prepare Sepharose-Ig anti-ovalbumin CT from 
Sepharose-Ig anti-ovalbumin. The activation steps 
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were in 50 mM TrissHCl, 150 mM NaCl, 5 mM CaC12 
(pH 7.4). 
Sheep erythrocyte stroma was obtained by hypo- 
tonic lysis of sheep erythrocytes [ 171. To prepare 
stroma---Cls, a 0.5 mg protein/ml suspension of stroma 
in PBS was incubated for 17 h at 20°C with 1% (v/v) 
glutaraldehyde, washed, resuspended at the same dilu- 
tion in PBS containing Cis and incubated for 5 h at 
20°C. Unreacted glutaraldehyde was saturated by 
1 I? mM lysine. 
To measure C4b binding, particles were incubated 
with 1251-labelled C4 for 30 nun at 37’C. Particles 
were separated by centrifugation and washed repeat- 
edly until the radioactivity of the supernatants reached 
background level. Proteolysis of C4 was assessed from 
SDS-PACE of the first supernatant. 
The different systems used are shown in table 1. 
3. Results 
3.1. C4b binding to EA CT 
C4b binds to EACH (fig.1); SDS-PAGE of the 
supernatants at the end of the incubation showed 
that all the C4 is proteolysed. In contrast, with EA. 
only a low level of fixation of C4 and fluid phase Cis- 
cleaved C4 was measured. The binding of C4b does 
not show a linear variation with increasing amounts 
of EAC?: this may reflect a disparity between the 
s 
v EA+Cis 
0‘ . . 
z 
. . 21 
I Y 7 EA I 
1 lo-’ 2 3 4 5 x number of cells
Fig.1. C4b binding to EACT: 5 ~g ‘251-labelled C4 were incu- 
bated as in section 2 in DGVB*’ supplemented with 1.5 mM 
CaCl, with varying concentrations of EACT (a), EA (0) or 
EA + 2.5 ~g Cis (m). Washes were with the incubation buffer 
as in section 2. 
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kinetics of C4 proteolysis and C4b deposition. 
Calculation from the amount of C4b bound by 
4 X lo8 EACi gives -4500 molecules C4b bound/ 
erythrocyte. 
3.2. C4b binding to Sepharose-subcomponents of Cl 
Fig.2 shows that Sepharose behaves as an acceptor 
for C4b; the fixation of C4b increases linearly with 
increasing concentrations of Sepharose. The link 
between C4b and Sepharose is resistant to 1% SDS 
but is sensitive to 50 mM methylamine at pH 10.4 
consistent with a nucleophile-sensitive covalent bond. 
The low binding of C4 to Sepharose-CisDFP (table 1, 
system 2) which does not cleave C4 as compared to 
Sepharose-Cis (table 1, system 1) indicates that pro- 
teolysis of C4 is a necessary step for its binding. 
Assuming that Cis accounts for half of the total 
protein bound on Sepharose-(Cir-Cis), 0.2 mg C-is 
is bound/ml Sepharose-(Cir-Cis) and 0.86 mg/ml 
of Sepharose-Cis: therefore the results in fig.2 show 
that Sepharose-(Cir-Cis) (table 1, system 3) binds 
-7-times more C4b/Cis than Sepharose-Cis (table 1, 
system 1). 
As Cis is able to dimerize in the presence of cal- 
cium, Sepharose-dimeric Cis was prepared either 
from Sepharose-monomeric Cis or Sepharose- 
0.05 0.10 
Packed Sepharose (ml) 
Fig.2. C4b binding to Sepharose-subcomponents of Cl: 5 c1g 
‘*SI-labelled C4 were incubated as in section 2 in 50 mM Tris- 
HCl, 100 mM NaCl, 5 mM CaCl, (pH 7.4) with varying con- 
-- 
centrations of Sepharose-Cis (0) or Sepharose-(I , s) (0); 
the values measured with Sepharose-CisDFP, Sepharose- 
CisDFP Ca2+-Cis, Sepharose-Cis-Ca’+-Cis and Sepha- 
rose-Cir-Ca’+-Cis are comprised in the hatched zone. 
Washes were with the incubation buffer as in section 2 then 
with 1% (w/v) aqueous SDS. 
Table 1 
Putative representation of the systems used as C4b acceptors 
1. Sepharose-Cis Cis covalently bound in the absence of calcium 
2. Sepharose-CisDFP CisDFP covalently bound as in I 
, Cir 
3. Sepharose\Eg Cir--Cis complex covalently bound in the presence of calcium 
4. Sepharose-Cis-Ca*+-Cis Cis first bound as in 1; second non-covalent binding of Cis in 
the presence of calcium 
5. Sepharose-CisDFP-Ca’+-Cis 
6. Sepharose-Cir-Ca2+-Cis 
7. Sepharose-Ig-Clq-Cir-Cis 
8. Sepharose-Ag-Ig-Clq-Cir-Cis 
9. Stroma-Cis 
As for 4 but with CisDFP in the first binding 
Cir covalently bound first: Cis bound in the second step, as in 
4 and 5 
Ig covalently bound fist: Cl fixed from serum in the second 
step, then activated to Cl 
Ag covalently bound first: Ig bound by immune affinity in the 
second step; then Cl fixed and activated in the third step, as in 7 
Cis covalently bound, in the absence of calcium 
153 
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0.05 0.10 
packed Sepharose (ml) 
Fig.3. C4b binding to Sepharose-lg anti-ovalbumin Cl: 5 pg 
‘251-labelled C4 were incubated as in section 2 in 50 mM Tris- 
HCI, 150 mM NaCl, 5 mM CaCl, (pH 7.4) containing STI (final 
cont. 50 fig/ml) with varying concentrations of Sepharose-Ig 
anti-ovalbumin CT. Washes were as in section 2 with the incu- 
bation buffer without ST1 then with 1% (w/v) aqueous SDS 
(e) 2 mg Ig/ml packed Sepharose; (0) 0.2 mg Ig/ml packed 
Sepharose. 
monomeric CIs blocked by DFP, incubated with 
soluble Cis in 5 mM CaCI,. These systems (table 1, 
systems 4,5) are very inefficient for C4b binding as 
well as a different Sepharose-C 1 r-C 1 s system (table 1. 
system 6) prepared from Sepharose-CIr incubated 
with soluble Cis in 5 mM CaCl,. 
3.3. C4b binding to Sepharose-Ig anti-ovalbumin Cj 
C4b binds to Sepharose-Ig anti-ovalbumin CT 
(table I, system 7) (tig.3). Anti-ovalbumin Ig was 
coupled to Sepharose 48 to generate a system com- 
parable to that described to evaluate C4b binding 
to Sepharose-ICC? (table 1, system 8). From an 
amount of 0.075 ml packed Sepharose, the amount 
of bound C4b increases proportionally to the Ig: 
Sepharose ratio. For lower amounts of Sepharose the 
hardly-detectable bound C4b, in the case of the lowest 
Ig concentration, may be attributed to particulate CT 
being limiting. 
3.4. C4b binding to Sepharose-ICC? 
Analysis of C4b binding to Sepharose-ICCi (table 
I, system 8) (fig.4) suggests a double localisation: 
one part of the radioactivity which is eluted by 1 M 
propionic acid corresponds to C4b binding to the Ig, 
the other part which is not eluted even by additional 
washes by 1% aqueous SDS corresponds to covalent 
binding to Sepharose. Only the binding to Sepharose 
0.05 0.10 
packed Sepharose (ml) 
Fig.4. C4b binding to Sepharose-ICCi: 5 pg (0) or 2.5 ng 
(0) of ‘251-labelled C4 were incubated as in section 2 in 50 
mM Tris-HCl, 100 mM NaCI, 5 mM CaCI, (pH 7.4) containing 
ST1 (final cont. 50 fig/ml) with varying concentrations of 
Sepharose-ICCi. Sequential washes were as in section 2 with 
the incubation buffer without STI, 50 mM Tris-HCl, 1 M 
NaCl (pH 7.4), 1 M propionic acid and 1% (w/v) aqueous SDS. 
Broken lines indicate the percentage of the input eluted by 
1 M propionic acid. 
increases as a function of Sepharose-ICCi concen- 
tration and appears proportional to the amount of 
C4 for the two quantities of C4 assayed. 
SDS-PAGE of a propionic-acid eluate is shown 
in fig.5: the distribution of the radioactivity is con- 
Fig.5. SDS-PAGE radioactivity pattern of a propionic acid 
eluate from Sepharose--1CCi after C4b binding. The propi- 
onic acid eluate corresponding to the highest radioactivity 
eluted in fig.4 was dialyzed against water and lyophilyzed. 
The lyophilysate was reduced and alkylated. Electrophoresis 
and counting were as in section 2. The arrows point to the 
position of the chains of C4. 
154 
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0.1 
erythrocyte stroma_Cis (mg protein) 
Fig.6. C4b binding to erythrocyte stroma-CTs: S ng ““I- 
labelled C4 were incubated as in section 2 in 50 mM Tris- 
HCl, 100 mM NaCl, 5 mM CaCl, (pH 7.4) containing ST1 
(final cont. 50 pg/n$) with varying concentrations of ery- 
throcyte stroma-Cls. Washes were as in section 2 with the 
incubation buffer without STI. For each point the binding 
of fluid phase Cis-cleaved C4 was subtracted. The erythrocyte 
stroma-Cis were prepared using 0.16 (0) or 0.32 (0) mg 
Cis/mg stroma protein. 
sistent with the pattern of radioactivity of ‘2SI-labelled 
C4b for p and y chains but shows a very sharp decrease 
of radioactivity in (Y’ chain concomitant with the 
presence of two additional higher-molecular-mass 
radioactive peaks. 
3.5. C4b binding to erythrocyte stroma-C?s 
C4b binds to stroma-Cis (table 1, system 9) as a 
function of the amount of stroma (lig.6). The Cis to 
stroma ratio appears to influence C4b binding; dou- 
bling Cis for the same amount of stroma induces a 
doubling of bound C4b. 
Assuming that the yield of stroma from the starting 
erythrocytes is lOO%, one can calculate that 450 mol- 
ecules of C4b are bound per erythrocyte, based on 
the highest value of C4b binding. 
4. Discussion 
As binding of a metastable activated form of C4 
represents a critical step in the formation of the C3 
convertase, the binding of this component was exam- 
ined using Sepharose and erythrocyte stroma as accep- 
tors, in reference to the EACi system. 
C4 binds to Sepharose after cleavage by Cis bound 
to the same matrix. When C4 is proteolysed by soluble 
Cis no significant binding occurs, which is also observed 
with EA as acceptor. Several models in which cis is 
located at different distances from the matrix (table 1) 
clearly show that the distance between the protease 
active site and the acceptor is the limiting factor in 
C4b binding, as shown for C3b binding to Sepharose- 
trypsin [ 181. Cis directly bound to Sepharose (table 
1, system 1) leads to a net binding of C4b whereas 
when it is at some distance no binding occurs. With 
a spacer as small as Cis itself or CisDFP (table 1, 
systems 4,5) only negligible amounts of C4b bind in 
spite of a total cleavage of C4; in this case the amount 
of C4b bound is of the same order as when C4 is incu- 
bated with Sepharose-CisDFP (table 1, system 2) 
which does not cleave C4. In the case of systems 7 
and 8 (table 1) where, respectively, Ig-Clq-Cir and 
Ag-Ig-C 1 q-Cir are between Cis and the acceptor 
Sepharose, the binding of C4 on the matrix can be 
explained by a suitable orientation of Cis. 
The immediate proteic environment of Cls seems 
to influence the efficiency of C4b binding: when the 
Cir-Cis complex is covalently linked to Sepharose 
(table 1, system 3), the system appears more efficient 
than when Cis is bound alone (table 1, system 1). In 
the same light the efficient binding of C4b reported 
above for systems 7 and 8 (table 1) can also be attrib- 
uted to the integration of Cis in Ci, in close proxim- 
ity to Cir. The role of Cir could be either to modulate 
the active site of neighbouring Cis or to orient C4. 
The low binding of C4b observed with system 6 
(table 1) in which Cir and Cis are sequentially bound 
can be explained by the only very partial reconstitu- 
tion of the Cir-cis complex. 
Both Sepharose and Ig participate as acceptor of 
C4b on Sepharose-ICC] (table 1, system 8). However 
more C4b binds to Sepharose than to Ig; the decrease 
of Ig-bound C4b with increasing concentrations of 
Sepharose-ICC1 suggests that C4b has a higher affinity 
for Sepharose than for Ig. The electrophoretic pattern 
of C4b eluted from Ig by propionic acid indicates two 
high-molecular mass peaks with could be accounted 
for by a’-_(y’ and o/-heavy Ig chain associations as 
observed with C4b bound to immune complex aggre- 
gates [7]. 
Fixation of C4b on stroma-Cis (table 1, system 9) 
is of the same order of magnitude as on EACi. EACi 
and to a less degree stroma-Cis show pseudo-satura- 
tion curves for the fixation of C4b with increasing 
concentrations of acceptor, suggesting a difference 
between the kinetics of proteolysis and binding ofC4b. 
155 
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